Historique
* Research Questions:
What types of cannabis products are produced and sold in Washington State?
What is the size of the cannabis market in Washington State three years after licensing cannabis production and sales for nonmedical purposes?
* [...]
Auteur J. P. CAULKINS
69 Documents disponibles écrits par cet auteur
To learn more about the possible outcomes of marijuana legalization in California, RAND researchers constructed a model based on a series of estimates of current consumption, current and future prices, how responsive use is to price changes, tax[...]![Basing drug scheduling decisions on scientific ranking of harmfulness: false promise from false premises [For debate]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_68028.webp?v=1771271529)
J. P. CAULKINS ; P. REUTER ; C. COULSON | 2011
Dans Addiction (Vol.106, n°11, November 2011) Article : PériodiqueIn recent years a number of studies have attempted to rank drugs by a single measure of harmfulness as the basis for decisions about scheduling and classification. These efforts are fundamentally flawed, both conceptually and methodologically. T[...]
B. KILMER ; J. P. CAULKINS ; G. MIDGETTE ; L. DAHLKEMPER ; R. J. MACCOUN ; R. L. PACULA | 2013
RapportIn 2012, Washington state voters passed Initiative 502 (I-502), which removed the prohibition on the production, distribution, and possession of marijuana for nonmedical purposes and required the state to regulate and tax a new marijuana industr[...]
B. KILMER ; J. P. CAULKINS ; R. L. PACULA ; P. H. REUTER | 2011
Dans Drug and Alcohol Dependence (Vol.119, n°1-2, December 2011) Article : PériodiqueHaving a sense of the scale of an illicit drug market is important for projecting consequences of alternative policy regimes. In this article, we review two general approaches to drug market estimation - supply-side and demand-side - before turn[...]
J. P. CAULKINS ; M. L. KILBORN | 2019
Dans American Journal of Drug and Alcohol Abuse (Vol.45, n°6, November 2019) Article : PériodiqueBackground: A number of countries are legalizing the supply of cannabis or are considering doing so. Beyond top-level design questions (e.g., who gets to supply and how will it be taxed?) lie many equally important and thorny regulatory issues c[...]
J. P. CAULKINS ; J. P. CAULKINS | 2024
Dans Addiction (Vol.119, n°9, September 2024) Article : PériodiqueBACKGROUND AND AIMS: Multiple countries are considering revising cannabis policies. This study aimed to measure long-term trends in cannabis use in the United States and compare them with alcohol use. DESIGN AND SETTING: Secondary analysis of U[...]![Cocaine's fall and marijuana's rise: questions and insights based on new estimates of consumption and expenditures in US drug markets [For debate]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_75705.webp?v=1771272879)
J. P. CAULKINS ; B. KILMER ; P. H. REUTER ; G. MIDGETTE | 2015
Dans Addiction (Vol.110, n°5, May 2015) Article : PériodiqueAims: Drug policy strategies and discussions often use prevalence of drug use as a primary performance indicator. However, three other indicators are at least as relevant: the number of heavy users, total expenditures and total amount consumed. [...]
J. H. JAFFE ; M. GOSSOP ; M. TYNDALL ; R. E. MANN ; P. REUTER ; W. HAO ; D. WEATHERBURN ; J. P. CAULKINS ; L. DEGENHARDT ; W. HALL ; C. DAY ; P. DIETZE ; L. COLLINS ; POINTER S. | 2005
PériodiqueNeuf commentaires sont proposés. Le premier, au regard des résultats de cette étude analyse un événement similaire survenu aux Etats-Unis en 1972/1973. Le deuxième s'intéresse aux conséquences du transfert de l'usage injectable d'héroïne vers l'[...]
B. KILMER ; J. TAYLOR ; J. P. CAULKINS ; P. A. MUELLER ; A. J. OBER ; B. PARDO ; R. SMART ; L. STRANG ; P. H. REUTER | 2018
RapportCurrent levels of opioid-related morbidity and mortality in the United States are staggering. Data for 2017 indicate that there were more than 47,000 opioid-involved overdose deaths, and one in eight adults now reports having had a family member[...]![Considering marijuana legalization carefully: insights for other jurisdictions from analysis for Vermont [For debate]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_78127.webp?v=1771272334)
J. P. CAULKINS ; B. KILMER | 2016
Dans Addiction (Vol.111, n°12, December 2016) Article : PériodiqueBackground and Aims: In 2014 the legislature of Vermont, USA passed a law requiring the Secretary of Administration to report on the consequences of legalizing marijuana. The RAND Corporation was commissioned to write that report. This paper sum[...]
J. P. CAULKINS ; B. KILMER ; M. A. R. KLEIMAN ; R. J. MACCOUN ; G. MIDGETTE ; P. OGLESBY ; R. L. PACULA ; P. REUTER | 2015
RapportMarijuana legalization is a controversial and multifaceted issue that is now the subject of serious debate. Since 2012, four U.S. states have passed ballot initiatives to remove prohibition and legalize a for-profit commercial marijuana industry[...]![Design considerations for legalizing cannabis: lessons inspired by analysis of California's Proposition 19 [For debate]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_69486.webp?v=1771275113)
J. P. CAULKINS ; B. KILMER ; R. J. MACCOUN ; R. L. PACULA ; P. REUTER | 2012
Dans Addiction (Vol.107, n°5, May 2012) Article : PériodiqueAims No modern jurisdiction has ever legalized commercial production, distribution and possession of cannabis for recreational purposes. This paper presents insights about the effect of legalization on production costs and consumption and highli[...]
R. L. PACULA ; B. KILMER ; A. C. WAGENAAR ; F. J. CHALOUPKA ; J. P. CAULKINS | 2014
Dans American Journal of Public Health (Vol.104, n°6, June 2014) Article : PériodiqueUntil November 2012, no modern jurisdiction had removed the prohibition on the commercial production, distribution, and sale of marijuana for nonmedical purposes - not even the Netherlands. Government agencies in Colorado and Washington are now [...]
